Salvage Chemotherapy with Docetaxel, Ifosfamide and Nedaplatin (DIN) for Patients with Advanced Germ Cell Tumors: A Preliminary Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Salvage Chemotherapy with Docetaxel, Ifosfamide and Nedaplatin (DIN) for Patients with Advanced Germ Cell Tumors: A Preliminary Report

Published:2013-04-25 Issue:7 Volume:43 Page:734-739
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Japanese Journal of Clinical Oncology

Author:

Yamada S.,Saito H.,Ohara S.,Yamashita S.,Mitsuzuka K.,Namiki S.,Miyazato M.,Kaiho Y.,Ito A.,Nakagawa H.,Ishidoya S.,Arai Y.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/43/7/734/5124793/hyt060.pdf

Reference27 articles.

1. Treatment of testicular cancer: a new and improved model.

2. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.

3. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor.

4. Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: The Institut Gustave Roussy experience

5. A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Chemotherapy Resistance in Germ Cell Tumors;Biomedicines;2022-04-22

2. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors;Annals of Oncology;2015-10

3. Current chemotherapeutic approaches for recurrent or refractory germ cell tumors;Urologic Oncology: Seminars and Original Investigations;2015-08

4. Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies;International Journal of Clinical Oncology;2015-06-28

5. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor;International Journal of Urology;2015-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3